Empired Ltd falls even as profit doubles: Is the stock a buy?

Empired Ltd (ASX:EPD) crashed 10% as its cash flow chokes under the weight of a recent acquisition. But is this a buying opportunity given management's promise of robust growth this and next year along with higher dividends?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Information technology services firm Empired Ltd (ASX: EPD) won't be joining its peers at the post-results season party with the stock crashing 11% in afternoon trade despite delivering a strong result and outlook.

The stock's tumble to a one-week low of 68 cents must be frustrating for shareholders given that management has posted a 74% surge in revenue to $50.5 million for the six months to end December 2014 and a dramatic turnaround in net profit to the tune of $1.2 million, compared with a loss of $36.9 million in the first half of the previous financial year.

Others in the sector, such as SMS Management & Technology Limited (ASX: SMX) and Data#3 Limited (ASX: DTL) have run up strongly after releasing their results, and there's growing confidence that the IT spending drought could finally be coming to an end in Australia.

It isn't an uncertain outlook that is causing pain for Empired either. Management has not only given full year revenue guidance for 2014-15 but has stuck its neck out even further by stating a 2015-16 target.

Empired said it is on track to deliver group sales at the upper end of its $110 million to $120 million forecast for the current financial year and is tipping a topline of $145 million to $165 million for the following year.

So why isn't this enough to keep investors happy?

Perhaps there is some disappointment that Empired didn't lift its 1 cent a share interim dividend given the very robust surge in profits (although it is promising an increase to full year distributions), but it's more likely the sharp deterioration in cash flows that is spooking the market and sparking concern that management may have bitten off more than it can chew with its recent $17.4 million acquisition of Intergen Ltd.

In spite of the 236% increase in first half earnings before interest, tax, depreciation and amortisation (EBITDA), the company recorded a net operating cash outflow of $3.7 million, which is nearly five times worse than the same period last year.

Management has tried to assure investors that this is no more than a one-off issue that's related to the acquisition of Intergen. About $1.8 million was deducted for transaction costs and there was a $2 million increase in working capital due to two large fixed cost projects.

Then there's IT issues causing invoicing delays. Oops! Did an IT company just say it was having IT issues?

There's also the difference between receivables and payables widening to $13 million for the period (this blowout increases working capital requirements), although management claims the invoicing problem has been rectified and that it was expecting positive cash flow in the second half.

Assuming management is right about its cash flow issues being a temporary hiccup, the share price drop could seem like an overreaction.

However, the issue is Empired is trading on a 2014-15 estimated price earnings multiple that is well in excess of 20x.

It is not unusual for high growth stocks to trade at such a premium. But to earn this premium, there cannot be any doubt about the quality and outlook of the company.

Empired has introduced doubt and that's why it is being punished.

However, I am still prepared to give management the benefit of the doubt. The risk-reward ratio also supports my view that the correction in the share price is temporary.

For that perspective, the weakness should be seen as a buying opportunity. Fingers crossed that management can deliver on its promises for the current half.

Motley Fool contributor Brendon Lau owns shares in Empired.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »